Conversely, the intensity of GLS2 expression was relatively high in normal colorectal (53.3%) and inflammatory hyperplasia tissues (64.7%), and was low in colorectal adenocarcinoma (p < 0.0001, Table S1). Here, GLS2 is linked to colorectal adenocarcinoma.